BRIEF-Dyne Therapeutics Receives FDA Fast Track Designation For Dyne-101

Reuters
21 Jan
BRIEF-Dyne <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Receives FDA Fast Track Designation For Dyne-101

Jan 21 (Reuters) - Dyne Therapeutics Inc DYN.O:

  • DYNE THERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR DYNE-101 FOR THE TREATMENT OF MYOTONIC DYSTROPHY TYPE 1

  • DYNE THERAPEUTICS INC - TO SUBMIT FOR U.S. ACCELERATED APPROVAL IN H1 2026

Source text: ID:nGNX9m9Xf2

Further company coverage: DYN.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10